[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334159-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334159-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-characteristics-and-prognostic-role-of-epha2-in-human-tumors-via-pan-cancer-analysis-research-paper","Molecular characteristics and prognostic role of EPHA2 in human tumors via pan-cancer analysis - Research paper","","Ephrin type-A receptor 2 (EPHA2) is markedly elevated across many tumors and contributes to cancer development and progression, yet pan-cancer characterization has been limited. Using The Cancer Genome Atlas data, researchers assessed EPHA2 expression and prognostic relevance across more than 10,000 samples spanning 33 cancer types. EPHA2 levels differed between normal and tumor tissues and were linked with patient outcomes. EPHA2 alterations mainly comprised missense mutations, with expression correlated to cancer-associated fibroblasts and enriched pro-oncogenic signaling pathways.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-characteristics-and-prognostic-role-of-epha2-in-human-tumors-via-pan-cancer-analysis-research-paper/334159/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-characteristics-and-prognostic-role-of-epha2-in-human-tumors-via-pan-cancer-analysis-research-paper/334159.png","ImageObject",300,407,{"name":42,"@type":43},"Seraphina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study designed to investigate about EPHA2?","Question",{"text":63,"@type":64},"The study analyzed EPHA2 expression status and its prognostic significance across cancers using a pan-cancer framework.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers analyze EPHA2 across cancer types?",{"text":68,"@type":64},"They mined The Cancer Genome Atlas data and characterized EPHA2 across more than 10,000 samples from 33 cancer types.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationships did the study report for EPHA2 in tumors?",{"text":72,"@type":64},"EPHA2 expression differed between normal and tumor tissues, correlated with prognosis, showed missense-dominant gene modifications, and associated with cancer-associated fibroblasts in many cancers. Functional enrichment linked EPHA2 to pro-oncogenic signaling pathways and its potential role in the tumor immune microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334159,1791000169,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":4},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","®  \n Observational Study   \nMolecular characteristics and prognostic role of EPHA2 in human tumors via pan-cancer analysis  \nGuoqiang Wang, MDa , Hui Xiao, PhDb , Zhipan Liang, MDc , Yuxin Feng, MDa , Liyu Wang, MDa , Ying Feng, MDa , Fen Guo, MDa , Luyao Zhang, MDa ,*  \n\n| Abstract\u003Cbr>The tyrosine kinase ephrin type-A receptor 2 (EPHA2) was remarkably elevated expressed in various tumors and plays a crucial role in cancer tumorigenesis and progression, while pan-cancer analyses are currently lacking. This study was designed to analyze the expression status and prognostic significance of EPHA2 in pan-cancer. By mining The Cancer Genome Atlas data, we performed a comprehensive and systematic characterization of EPHA2 across >10,000 samples of 33 types of cancer. EPHA2 expressions were substantially different in most of the normal control and tumor tissues, and it was considerably associated with the prognosis of tumor patients. EPHA2 gene modifications in malignant tumors were mainly missense mutations. There was a significant correlation between EPHA2 expression and cancer-associated fibroblasts in most The Cancer Genome Atlas cancers. Furthermore, functional enrichment analysis showed that the biological role of EPHA2 in tumors was mainly involved in some noticeably pro-oncogenic pathways, such as the Ras signaling pathway, PI3K-Akt signaling pathway, ErbB signaling pathway, MAPK signaling pathway, etc. This study provided the first pan-cancer analyses of EPHA2 in various tumors, and EPHA2 was potentially involved in many cancer types and can be developed as candidates for cancer diagnosis, prognosis, and therapeutic biomarkers. In addition, EPHA2 seemed to be a key modulator of the tumor immune microenvironment and might be a potential biomarker in predicting the immunotherapeutic efficacy for cancer patients. |\n| --- |\n| Abbreviations: BRCA = breast invasive carcinoma, CAF = cancer-associated fibroblast , CESC = cervical squamous cell carcinoma and endocervical adenocarcinoma, CNA = copy number alteration, COAD = colon adenocarcinoma, CPTAC = Clinical Proteomic Tumor Analysis Consortium, DC = dendritic cell, DFS = Disease-Free Survival, EPHA2 = ephrin type-A receptor 2, ESCA = esophageal carcinoma, GBM = glioblastoma multiforme, GEPIA = Gene Expression Profiling Interactive Analysis, GTEx = Genotype-Tissue Expression, HNSC = head and neck squamous cell carcinoma, KICH = kidney chromophobe, KIRC = kidney renal clear cell carcinoma, LGG = brain lower grade glioma, LIHC = liver hepatocellular carcinoma, LUAD = lung adenocarcinoma, LUSC = lung squamous cell carcinoma, MSI = microsatellite instability, MΦ = macrophages, OS = overall survival, PAAD = pancreatic adenocarcinoma, PCPG = pheochromocytoma and paraganglioma, PFS = progression-free survival, PRAD = prostate adenocarcinoma, READ = rectum adenocarcinoma, SKCM = skin cutaneous melanoma, STAD = stomach adenocarcinoma, TCGA = The Cancer Genome Atlas, TGCT = testicular germ cell tumors, THCA = thyroid carcinoma, TIMER = Tumor IMmune Estimation Resource, TMB = tumor mutation burden, UCEC = uterine corpus endometrial carcinoma. |\n| Keywords: cancer prognosis, EPHA2 receptors, pan-cancer analysis, survival analysis |\n\n1. Introduction  \nTumor has attracted widespread attention as a major disease substantially threatening human life and well-being. Studies have invested significant manpower and resources from  \ndifferent countries globally, resulting in substantial advancements. Tumors represent an intricate disease for which a comprehensive understanding remains elusive. Hence, oncology investigation remains preliminary, necessitating more exploration, continuing enhancement, and progress in numerous  \nGW, HX, and ZL contributed equally to this work.  \nThis work was supported by the Science and Technology Development Fund of Nanjing Medical University (NMUB20220178), and the Science and Technology Program of Suzhou (SKY2023207).  \nThe authors have no conflicts of interest to disc","cbCaiuN6YySV8IU2","https://ap.wps.com/l/cbCaiuN6YySV8IU2","pdf",1625029,12,"English","# Abstract\n## Abbreviations\n## Keywords\n# Introduction","[{\"question\":\"What was the study designed to investigate about EPHA2?\",\"answer\":\"The study analyzed EPHA2 expression status and its prognostic significance across cancers using a pan-cancer framework.\"},{\"question\":\"How did the researchers analyze EPHA2 across cancer types?\",\"answer\":\"They mined The Cancer Genome Atlas data and characterized EPHA2 across more than 10,000 samples from 33 cancer types.\"},{\"question\":\"What relationships did the study report for EPHA2 in tumors?\",\"answer\":\"EPHA2 expression differed between normal and tumor tissues, correlated with prognosis, showed missense-dominant gene modifications, and associated with cancer-associated fibroblasts in many cancers. Functional enrichment linked EPHA2 to pro-oncogenic signaling pathways and its potential role in the tumor immune microenvironment.\"}]","Molecular characteristics and prognostic role of EPHA2 in human tumors via pan-cancer analysis - Research paper | PDF",1790005536]